CobaltMaghrebV1, Main, Exploration, bibRecord, 000D14

Current treatment of Hodgkin’s disease

Identifieur interne : 000D14 ( Main/Exploration ); précédent : 000D13; suivant : 000D15

Current treatment of Hodgkin’s disease

Auteurs : Houchingue Eghbali [France] ; Pierre Soubeyran [France] ; Nadine Tchen [France] ; Isabelle De Mascarel [France] ; Isabelle Soubeyran [France] ; Pierre Richaud [France]

Source :

Critical Reviews in Oncology / Hematology [ 1040-8428 ] ; 2000.

RBID : ISTEX:941B29522CD2CD8C9DB59FE619FB2DB2F8E56989

Abstract

In spite of the fact that Hodgkin’s disease (HD) remains still an enigma its management and treatment yield a cure rate of about 80% of all patients. However, this management has two limits: on one side favourable cases which should not be overtreated because of unacceptable side-effects, and on the other side very unfavourable cases which should be treated differently because of a very high rate of failure and/or relapse. Then it becomes necessary to precise as thoroughly as possible these two limits in order to choose the adequate treatment for the patient. Prognostic factors based on patient and disease characteristics allow a relatively exact classification of favourable and unfavourable cases. This distinction in two prognostic groups has therapeutic implications in terms of chemotherapy (regimen, duration) and radiotherapy (extension, doses). Other specific situations have to be considered, e.g. pediatric cases, pregnancy, old age and HIV-infected patients who need an adapted management according to very different situations.

Url:

https://api.istex.fr/document/941B29522CD2CD8C9DB59FE619FB2DB2F8E56989/fulltext/pdf

DOI: 10.1016/S1040-8428(99)00070-0

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Istex, to step Corpus: 001A30
to stream Istex, to step Curation: 001414
to stream Istex, to step Checkpoint: 000622
to stream Main, to step Merge: 000D39
to stream Main, to step Curation: 000D14

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Current treatment of Hodgkin’s disease</title>
<author><name sortKey="Eghbali, Houchingue" sort="Eghbali, Houchingue" uniqKey="Eghbali H" first="Houchingue" last="Eghbali">Houchingue Eghbali</name>
</author>
<author><name sortKey="Soubeyran, Pierre" sort="Soubeyran, Pierre" uniqKey="Soubeyran P" first="Pierre" last="Soubeyran">Pierre Soubeyran</name>
</author>
<author><name sortKey="Tchen, Nadine" sort="Tchen, Nadine" uniqKey="Tchen N" first="Nadine" last="Tchen">Nadine Tchen</name>
</author>
<author><name sortKey="De Mascarel, Isabelle" sort="De Mascarel, Isabelle" uniqKey="De Mascarel I" first="Isabelle" last="De Mascarel">Isabelle De Mascarel</name>
</author>
<author><name sortKey="Soubeyran, Isabelle" sort="Soubeyran, Isabelle" uniqKey="Soubeyran I" first="Isabelle" last="Soubeyran">Isabelle Soubeyran</name>
</author>
<author><name sortKey="Richaud, Pierre" sort="Richaud, Pierre" uniqKey="Richaud P" first="Pierre" last="Richaud">Pierre Richaud</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:941B29522CD2CD8C9DB59FE619FB2DB2F8E56989</idno>
<date when="2000" year="2000">2000</date>
<idno type="doi">10.1016/S1040-8428(99)00070-0</idno>
<idno type="url">https://api.istex.fr/document/941B29522CD2CD8C9DB59FE619FB2DB2F8E56989/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001A30</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001A30</idno>
<idno type="wicri:Area/Istex/Curation">001414</idno>
<idno type="wicri:Area/Istex/Checkpoint">000622</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000622</idno>
<idno type="wicri:doubleKey">1040-8428:2000:Eghbali H:current:treatment:of</idno>
<idno type="wicri:Area/Main/Merge">000D39</idno>
<idno type="wicri:Area/Main/Curation">000D14</idno>
<idno type="wicri:Area/Main/Exploration">000D14</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Current treatment of Hodgkin’s disease</title>
<author><name sortKey="Eghbali, Houchingue" sort="Eghbali, Houchingue" uniqKey="Eghbali H" first="Houchingue" last="Eghbali">Houchingue Eghbali</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut Bergonié, Regional Cancer Centre, 180, rue de Saint-Genès, F-33076 Bordeaux Cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
<affiliation></affiliation>
</author>
<author><name sortKey="Soubeyran, Pierre" sort="Soubeyran, Pierre" uniqKey="Soubeyran P" first="Pierre" last="Soubeyran">Pierre Soubeyran</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut Bergonié, Regional Cancer Centre, 180, rue de Saint-Genès, F-33076 Bordeaux Cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Tchen, Nadine" sort="Tchen, Nadine" uniqKey="Tchen N" first="Nadine" last="Tchen">Nadine Tchen</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut Bergonié, Regional Cancer Centre, 180, rue de Saint-Genès, F-33076 Bordeaux Cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="De Mascarel, Isabelle" sort="De Mascarel, Isabelle" uniqKey="De Mascarel I" first="Isabelle" last="De Mascarel">Isabelle De Mascarel</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut Bergonié, Regional Cancer Centre, 180, rue de Saint-Genès, F-33076 Bordeaux Cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Soubeyran, Isabelle" sort="Soubeyran, Isabelle" uniqKey="Soubeyran I" first="Isabelle" last="Soubeyran">Isabelle Soubeyran</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut Bergonié, Regional Cancer Centre, 180, rue de Saint-Genès, F-33076 Bordeaux Cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Richaud, Pierre" sort="Richaud, Pierre" uniqKey="Richaud P" first="Pierre" last="Richaud">Pierre Richaud</name>
<affiliation wicri:level="3"><country xml:lang="fr">France</country>
<wicri:regionArea>Institut Bergonié, Regional Cancer Centre, 180, rue de Saint-Genès, F-33076 Bordeaux Cedex</wicri:regionArea>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Critical Reviews in Oncology / Hematology</title>
<title level="j" type="abbrev">ONCH</title>
<idno type="ISSN">1040-8428</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="2000">2000</date>
<biblScope unit="volume">35</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="49">49</biblScope>
<biblScope unit="page" to="73">73</biblScope>
</imprint>
<idno type="ISSN">1040-8428</idno>
</series>
<idno type="istex">941B29522CD2CD8C9DB59FE619FB2DB2F8E56989</idno>
<idno type="DOI">10.1016/S1040-8428(99)00070-0</idno>
<idno type="PII">S1040-8428(99)00070-0</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1040-8428</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In spite of the fact that Hodgkin’s disease (HD) remains still an enigma its management and treatment yield a cure rate of about 80% of all patients. However, this management has two limits: on one side favourable cases which should not be overtreated because of unacceptable side-effects, and on the other side very unfavourable cases which should be treated differently because of a very high rate of failure and/or relapse. Then it becomes necessary to precise as thoroughly as possible these two limits in order to choose the adequate treatment for the patient. Prognostic factors based on patient and disease characteristics allow a relatively exact classification of favourable and unfavourable cases. This distinction in two prognostic groups has therapeutic implications in terms of chemotherapy (regimen, duration) and radiotherapy (extension, doses). Other specific situations have to be considered, e.g. pediatric cases, pregnancy, old age and HIV-infected patients who need an adapted management according to very different situations.</div>
</front>
</TEI>
<affiliations><list><country><li>France</li>
</country>
<region><li>Aquitaine</li>
<li>Nouvelle-Aquitaine</li>
</region>
<settlement><li>Bordeaux</li>
</settlement>
</list>
<tree><country name="France"><region name="Nouvelle-Aquitaine"><name sortKey="Eghbali, Houchingue" sort="Eghbali, Houchingue" uniqKey="Eghbali H" first="Houchingue" last="Eghbali">Houchingue Eghbali</name>
</region>
<name sortKey="De Mascarel, Isabelle" sort="De Mascarel, Isabelle" uniqKey="De Mascarel I" first="Isabelle" last="De Mascarel">Isabelle De Mascarel</name>
<name sortKey="Richaud, Pierre" sort="Richaud, Pierre" uniqKey="Richaud P" first="Pierre" last="Richaud">Pierre Richaud</name>
<name sortKey="Soubeyran, Isabelle" sort="Soubeyran, Isabelle" uniqKey="Soubeyran I" first="Isabelle" last="Soubeyran">Isabelle Soubeyran</name>
<name sortKey="Soubeyran, Pierre" sort="Soubeyran, Pierre" uniqKey="Soubeyran P" first="Pierre" last="Soubeyran">Pierre Soubeyran</name>
<name sortKey="Tchen, Nadine" sort="Tchen, Nadine" uniqKey="Tchen N" first="Nadine" last="Tchen">Nadine Tchen</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/CobaltMaghrebV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D14 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D14 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Terre
   |area=    CobaltMaghrebV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:941B29522CD2CD8C9DB59FE619FB2DB2F8E56989
   |texte=   Current treatment of Hodgkin’s disease
}}

This area was generated with Dilib version V0.6.32.
Data generation: Tue Nov 14 12:56:51 2017. Site generation: Mon Feb 12 07:59:49 2024

	Serveur d'exploration sur le cobalt au Maghreb
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le cobalt au Maghreb

Current treatment of Hodgkin’s disease

Current treatment of Hodgkin’s disease

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri